Skip to content

Giving lignocaine intravenously for upper limb surgeries

A Comparative study of sensory and motor effects of magnesium sulphate versus clonidine as an adjuvant to lignocaine in intravenous regional anesthesia for upper limb surgeries - nill

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059549
Enrollment
70
Registered
2023-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified Health Condition 2: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: CLONIDINE: comparison of sensory and motor effects of magnesium sulphate versus clonidine 1mcg/kg as an adjuvant to preservative free 0.5% lignocaine 3mg/kg in IVRA as a stat dose Contr

Sponsors

Dr Kiran A V
Lead Sponsor
Dr Sumayya E
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are posted for elective upper limb surgeries lasting ASA I and II Patients giving informed written consent.

Exclusion criteria

Exclusion criteria: Patients with coagultaion disoders sickle cell disease raynauds disease. Morbidly obese patients.

Design outcomes

Primary

MeasureTime frame
sensory and motor effects of magnesium sulphate versus clonidine when added to lignocaine in intravenous regional anesthesia for upper limb surgeriesTimepoint: 1 Year

Secondary

MeasureTime frame
To compare the duration of post operative analgesia and frequency of rescue analgesic requirement after addition of magnesium sulphate versus clonidine to lignocaine. To describe any side effects of magnesium sulphate and clonidine.Timepoint: 24 hours

Countries

India

Contacts

Public ContactDr sumayya e

Mandya Institute of Medical Sciences

virupaksha2614@yahoo.com8073147191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026